Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
Hi mathsprof
Appreciate all the details of the deal, which as we all know has been truly dissected on this bb and totally agree in what you have stated below - but, I look at betterment and actually wonder whether RF in supporting Sareum rather than using their "standard business model" could possibly have made a more substantial return - only a thought and put to bed as this not the RF bb.
Returning to Sareum, is there betterment in potential funding arrangements as we are certainly in a better position with SDC-1801 and SRA737 than we were when the RF decision was announced on 4th August last year, like RF cash balance, who knows?
GLA
Hi mathsprof
I'm not so sure that was a sell looking at the sp either side of the timed transaction - also, 5-10% on a £2m share loan against warrants at £1.47 or a share that could quite easily rise, have RF got the cash balance for the 3rd and 4th deposits given their current trading status - only an opinion, but lots in the mixer I feel!
GLA
HBD all good thanks, likewise yourself I trust - yes I'm intrigued by RF's strategy as ultimately to make serious money they need Sareum aka sp to be high, otherwise, decimate the sp and you just either sit on a lot of cheap shares and never cover anymore than your loan value and/or have the loan repaid!
There is no doubt the BoD's next RNS is crucial and needs to be delivered with concise and clear intent of Sareum's pathway and progression as a Company over the next 12 month's - here's hoping they do and start to recover their true potential both in the clinic and the market places!
GLA
Hi HBD as I have said previously the RF funding agreement doesn't have to be fulfilled and can be terminated by settlement of the amount borrowed, we now have "meat on the bone" - who knows if that opens doors to different funding, licensing, investment, whatever think back to the time the HNWI's we're in a better position with development now, who knows? - some questioned have RF played a blinder, lets see, they could end up with very few shares if they are dumping shares and the "bridging loan" repaid!!
Ultimately, it's a waiting game on news, I have my quota of shares and don't need to add but can see why people would want to buy at these prices - as they say DYOR,
GLA
Hi Aber, no argument we've read each others posts here for a long time, all I would say is ultimately all BoD decisions are a collective vote not the action of a single member.
Now we have progressed in Phase1a, I'm taking a philosophical view that if they achieve 1b, have the RF/alternative funding in a better place the sp should re rate - get to PH forecast of £3 plus maybe £4 most on this bb (appreciate a small number may not) would have made money and/or a least recovered stake - as an armchair poster (after all that's all we are) I'ill be more than happy with my return! - admittedly, it was between 12p and 16p old money but as per my moniker, getting on a bit this year and above would be very nice after getting my original stake out in 2021.
GLA
Krusty and I not saying they have - I used the word "if" - it's just an opinion on a bb that's all!
Agree some pi's may have decided to get out, but, I think you would agree they wouldn't have done so before any selling down by RF going back as far as last August.
Anyway, time for a walk, hopefully, today's momentum continues and sticks which is of more concern to me!
GLA
Granted Krusty. but, lets just say the general conversation at the AGM, along with the Q & A answer that a register of sells is being kept would suggest they have imho!
If as you say they haven't sold a single share, the gap is closing this morning on the dilution - long may it continue!
GLA
RF selling down might not be their best option, now we have progressed in Phase1a as I've I mentioned previously gives an opportunity for alternative funding - the terms of the RF facility says it is terminated on repayment of such - do that and RF has "bridged" us to get where we are today and they are left with whatever shares they haven't sold.
As I said we do have "meat on the bones" now which hopefully will allow for a more beneficial funding arrangement akin to the Sareum business model.
GLA
This is RF driven, they will need to be careful as if they enforce bankruptcy, they will not recover their loan and be left with a batch of worthless shares, same as SP and us - TM and JR will go with the science, that's my worry and should be the BoD's if RF are trigger happy!
More likely, MM manipulation and dare say concerned pi's saying enough is enough.
I disagreed with Mr Smith opening statement at the AGM about putting Sareum up for sale now we are progressing through 1a at £3.50 and start a bidding war, if equity cant be raised to walk away from RF, I have to concede that may be our only option.
Perhaps a statement from the board today, clarifying the RF situation and how they see us progressing over the next 6 months into Phase1b is needed, after all, good management is standing up, communicating and being counted in bad times as well as good.
GLA
Fanti, presuming you are addressing me, firstly, you're not bothering me, it's an open bb!
Regarding your query, yes I did run a business (I'm now retired) and as it is still a successful concern, assume (rightly or wrongly) I knew something about what I was doing.
As for "mobilising" it's success, appreciate buzz words are the norm these days but I'm not sure we used texts as you suggest to generate potential interest!
The purpose of my posting was not about above, it was to highlight the RNS landmark of Sareum reaching a milestone point as a drug development company and you and another poster discussing the relevance of them announcing such - personally, I found that baffling as it was purely telling one and all where they were in such development, given the criticism of lack of communication by this bb.
If I've offended, sorry, but that's how I see it!
GLA
The bb screams for better communications, the BoD releases a RNS stating we have completed 2 of the 3 "physical aspects" of a Phase1a clinical trial of our own compound for the first time and some start debating the reasoning the BoD released it - as you said HBD, every day's a school day!!
Off for a beer!
GLA
After what was great news this morning regarding completion of the SAD and Food parts of the Phase 1a clinical trail in Oz.
Yes we know the RF finance has strangled us, but why this option? What happened to make this the "best" option?
It's not mentioned on the bb much but it was estimated that £1.7m was "lost" due to the MHRA postponement/setting up in Oz and if memory serves me right associated tax credits would have been allowed - so perhaps in a bit of a pickle, that needed instant rectification to get Oz up and running!
I'm not going to go over what they could/should/haven't done, simply cause it's not going to change, however, to use my earlier term there is "meat on the bone" and now is the time for SP to show his full worth, which I believe he will whether that is by refinancing or licensing out, after all, I believe 1802 could also possibly have it's door opened on the back of 1801trial (I'm sure I will be corrected if this isn't the case) and obviously, something is going on with SRA737.
My point, we are in a better place than yesterday, the sp just isn't reflecting it but the BoD should now have the "tools" to provide that much publicised "Shareholder Value"
GLA
FYI
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.nasdaq.com/docs/2407-Q18%20NPM%20RSU%20Whitepaper_1115.pdf
GLA